Lot 1
No lot description published.
Buyer: Queen's University Belfast →
View official notice ↗Official source
The Future Medicines Institute (FMI) requires a Surface Plasmon Resonance (SPR) system with advanced capabilities for real-time, label-free analysis of biomolecular interactions. (Maximum budget available for Equipment inclusive of 3 years extended warranty & annual preventative maintenance is is £330,000). The primary objective of procuring an SPR device is to enhance FMI’s capacity to characterise binding kinetics, affinity, and specificity of biomolecular interactions, thereby strengthening its protein science and drug discovery workflows. The proposed system must: • Provide precise kinetic and affinity measurements for a wide range of biomolecular interactions, including protein–protein, protein–antibody, and protein–small molecule binding. • Deliver high sensitivity and reproducibility to ensure reliable and quantitative data across experiments. • Support automation and high-throughput analysis, enabling efficient screening of large sample sets. • Include robust data analysis software for comprehensive kinetic modelling and data interpretation. • Offer versatile assay configurations, supporting various experimental formats and immobilisation chemistries. • Integrate seamlessly with upstream and downstream workflows, including protein purification and structural analysis. The procurement of a high-performance SPR system directly supports FMI’s broader goals of: • Accelerating drug discovery through rapid identification and characterisation of therapeutic candidates. • Enhancing biopharmaceutical research by enabling detailed analysis of binding mechanisms critical to biologics development. • Facilitating translational research by bridging fundamental molecular interaction studies with clinical and therapeutic applications. This procurement will provide direct benefit to research scientists by: • Reducing manual intervention and experimental variability through automation and streamlined workflows. • Enhancing data quality with high-resolution detection and advanced signal processing for accurate kinetic profiling. • Please note: - The execution of this tender & contract will be solely dependent on grant funding being received, which is estimated to be confirmed in November 2025. • No award will be made, or orders issued until the grant funding has been confirmed. If grant funding is not secured, the market will be notified, and this procurement exercise will be stood down.
No lot description published.
No usable CPV category has been published, so a comparable market set cannot yet be built.
No planning milestones published.
No linked framework, prior procurement or reprocurement published.
Diagnostic view. “Not published” means this current release does not provide a value.
| OCID | ocds-h6vhtk-05cdd5 |
|---|---|
| Latest release ID | 003495-2026 |
| Latest release timestamp | Thu Jan 15 2026 13:35:44 GMT+0000 (Coordinated Universal Time) |
| Source | find-a-tender |
| Official notice URL | https://www.find-tender.service.gov.uk/Notice/072246-2025 |
| Tender status | complete |
| Procurement method | open |
| Procurement method details | Open procedure |
| Main procurement category | Not published |
| Above threshold | Not published |
| Legal basis | 2023/54 |
| Tender period: start | Not published |
| Tender period: end | Not published |
| Expression of interest deadline | Not published |
| Enquiry deadline | Not published |
| Award period: start | Not published |
| Award period: end | Not published |
| Submission method details | Not published |
| Submission languages | Not published |
| Electronic catalogue policy | Not published |
| Total tender value | Not published |
| Tender lots in source | 1 |
| Tender items in source | 0 |
| Tender documents in source | 1 |
| Awards in latest release | 1 |
| Contracts in latest release | 1 |
| Parties in latest release | 2 |
| Date | Event | Reference |
|---|---|---|
| 15 Jan 2026 | award, contract | 003495-2026 |
| 22 Dec 2025 | award, contract | 085607-2025 |
| 10 Nov 2025 | tenderUpdate | 072246-2025 |
| 27 Oct 2025 | tenderUpdate | 068436-2025 |
| 17 Oct 2025 | tender | 066106-2025 |
| 16 Oct 2025 | planning | 065844-2025 |
Unmodified official OCDS data retained by Tenderline for this procurement process.
{
"id": "003495-2026",
"tag": [
"award",
"contract"
],
"date": "2026-01-15T13:35:44Z",
"ocid": "ocds-h6vhtk-05cdd5",
"buyer": {
"id": "GB-NIC-101788",
"name": "Queen's University Belfast"
},
"awards": [
{
"id": "1",
"items": [
{
"id": "1",
"relatedLot": "1",
"deliveryAddresses": [
{
"region": "UKN06",
"country": "GB",
"countryName": "United Kingdom"
}
],
"additionalClassifications": [
{
"id": "38430000",
"scheme": "CPV",
"description": "Detection and analysis apparatus"
},
{
"id": "38432000",
"scheme": "CPV",
"description": "Analysis apparatus"
}
]
}
],
"status": "active",
"suppliers": [
{
"id": "GB-PPON-PRYY-4533-ZMZR",
"name": "Global Life Sciences Solutions Operations UK Limited"
}
],
"relatedLots": [
"1"
],
"mainProcurementCategory": "goods"
}
],
"tender": {
"id": "250262",
"lots": [
{
"id": "1",
"status": "complete"
}
],
"title": "250262 - Contract for Supply, Delivery, Installation & Commissioning of a Surface Plasmon Resonance (SPR) System.",
"status": "complete",
"coveredBy": [
"GPA",
"CPTPP"
],
"documents": [
{
"id": "conflictOfInterest",
"description": "Not published",
"documentType": "conflictOfInterest"
}
],
"legalBasis": {
"id": "2023/54",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents",
"scheme": "UKPGA"
},
"description": "The Future Medicines Institute (FMI) requires a Surface Plasmon Resonance (SPR) system with advanced capabilities for real-time, label-free analysis of biomolecular interactions.\n(Maximum budget available for Equipment inclusive of 3 years extended warranty & annual preventative maintenance is is £330,000).\nThe primary objective of procuring an SPR device is to enhance FMI’s capacity to characterise binding kinetics, affinity, and specificity of biomolecular interactions, thereby strengthening its protein science and drug discovery workflows.\nThe proposed system must:\n•\tProvide precise kinetic and affinity measurements for a wide range of biomolecular interactions, including protein–protein, protein–antibody, and protein–small molecule binding.\n•\tDeliver high sensitivity and reproducibility to ensure reliable and quantitative data across experiments.\n•\tSupport automation and high-throughput analysis, enabling efficient screening of large sample sets.\n•\tInclude robust data analysis software for comprehensive kinetic modelling and data interpretation.\n•\tOffer versatile assay configurations, supporting various experimental formats and immobilisation chemistries.\n•\tIntegrate seamlessly with upstream and downstream workflows, including protein purification and structural analysis.\nThe procurement of a high-performance SPR system directly supports FMI’s broader goals of:\n•\tAccelerating drug discovery through rapid identification and characterisation of therapeutic candidates.\n•\tEnhancing biopharmaceutical research by enabling detailed analysis of binding mechanisms critical to biologics development.\n•\tFacilitating translational research by bridging fundamental molecular interaction studies with clinical and therapeutic applications.\nThis procurement will provide direct benefit to research scientists by:\n•\tReducing manual intervention and experimental variability through automation and streamlined workflows.\n•\tEnhancing data quality with high-resolution detection and advanced signal processing for accurate kinetic profiling.\n•\tPlease note: - The execution of this tender & contract will be solely dependent on grant funding being received, which is estimated to be confirmed in November 2025. \n•\tNo award will be made, or orders issued until the grant funding has been confirmed. If grant funding is not secured, the market will be notified, and this procurement exercise will be stood down.",
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure"
},
"parties": [
{
"id": "GB-NIC-101788",
"name": "Queen's University Belfast",
"roles": [
"buyer"
],
"address": {
"region": "UKN06",
"country": "GB",
"locality": "Belfast",
"postalCode": "BT7 1NN",
"countryName": "United Kingdom",
"streetAddress": "University Rd"
},
"details": {
"classifications": [
{
"id": "publicAuthoritySubCentralGovernment",
"scheme": "UK_CA_TYPE",
"description": "Public authority - sub-central government"
},
{
"id": "GB-NIR",
"scheme": "UK_CA_DEVOLVED_REGULATIONS",
"description": "Northern Irish devolved regulations apply"
}
]
},
"identifier": {
"id": "101788",
"scheme": "GB-NIC"
},
"contactPoint": {
"name": "Shauna Ryan",
"email": "procurement@qub.ac.uk"
}
},
{
"id": "GB-PPON-PRYY-4533-ZMZR",
"name": "Global Life Sciences Solutions Operations UK Limited",
"roles": [
"supplier"
],
"address": {
"region": "UKJ13",
"country": "GB",
"locality": "Little Chalfont,",
"postalCode": "HP7 9NA",
"countryName": "United Kingdom",
"streetAddress": "Amersham Place"
},
"details": {
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "PRYY-4533-ZMZR",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "tendersukie@cytiva.com"
}
}
],
"language": "en",
"contracts": [
{
"id": "1",
"title": "250262 - Contract for Supply, Delivery, Installation & Commissioning of a Surface Plasmon Resonance (SPR) System.",
"value": {
"currency": "GBP",
"amountGross": 700000
},
"period": {
"endDate": "2029-01-08T23:59:59+00:00",
"startDate": "2026-01-09T00:00:00+00:00",
"maxExtentDate": "2036-01-08T23:59:59+00:00"
},
"status": "active",
"awardID": "1",
"renewal": {
"description": "option to extend maintenance, software \nupdates/development, the supply of consumables and ancillary items, beyond this \nperiod for a further period of up to 10 years or the end of useful life of the \nequipment."
},
"documents": [
{
"id": "003495-2026",
"url": "https://www.find-tender.service.gov.uk/Notice/003495-2026",
"format": "text/html",
"noticeType": "UK7",
"description": "Contract details notice on Find a Tender",
"documentType": "contractNotice",
"datePublished": "2026-01-15T13:35:44Z"
}
],
"dateSigned": "2026-01-09T00:00:00+00:00",
"hasRenewal": true,
"aboveThreshold": true
}
],
"initiationType": "tender"
}{
"id": "003495-2026",
"tag": [
"award",
"contract"
],
"date": "2026-01-15T13:35:44Z",
"ocid": "ocds-h6vhtk-05cdd5",
"buyer": {
"id": "GB-NIC-101788",
"name": "Queen's University Belfast"
},
"awards": [
{
"id": "1",
"items": [
{
"id": "1",
"relatedLot": "1",
"deliveryAddresses": [
{
"region": "UKN06",
"country": "GB",
"countryName": "United Kingdom"
}
],
"additionalClassifications": [
{
"id": "38430000",
"scheme": "CPV",
"description": "Detection and analysis apparatus"
},
{
"id": "38432000",
"scheme": "CPV",
"description": "Analysis apparatus"
}
]
}
],
"status": "active",
"suppliers": [
{
"id": "GB-PPON-PRYY-4533-ZMZR",
"name": "Global Life Sciences Solutions Operations UK Limited"
}
],
"relatedLots": [
"1"
],
"mainProcurementCategory": "goods"
}
],
"tender": {
"id": "250262",
"lots": [
{
"id": "1",
"status": "complete"
}
],
"title": "250262 - Contract for Supply, Delivery, Installation & Commissioning of a Surface Plasmon Resonance (SPR) System.",
"status": "complete",
"coveredBy": [
"GPA",
"CPTPP"
],
"documents": [
{
"id": "conflictOfInterest",
"description": "Not published",
"documentType": "conflictOfInterest"
}
],
"legalBasis": {
"id": "2023/54",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents",
"scheme": "UKPGA"
},
"description": "The Future Medicines Institute (FMI) requires a Surface Plasmon Resonance (SPR) system with advanced capabilities for real-time, label-free analysis of biomolecular interactions.\n(Maximum budget available for Equipment inclusive of 3 years extended warranty & annual preventative maintenance is is £330,000).\nThe primary objective of procuring an SPR device is to enhance FMI’s capacity to characterise binding kinetics, affinity, and specificity of biomolecular interactions, thereby strengthening its protein science and drug discovery workflows.\nThe proposed system must:\n•\tProvide precise kinetic and affinity measurements for a wide range of biomolecular interactions, including protein–protein, protein–antibody, and protein–small molecule binding.\n•\tDeliver high sensitivity and reproducibility to ensure reliable and quantitative data across experiments.\n•\tSupport automation and high-throughput analysis, enabling efficient screening of large sample sets.\n•\tInclude robust data analysis software for comprehensive kinetic modelling and data interpretation.\n•\tOffer versatile assay configurations, supporting various experimental formats and immobilisation chemistries.\n•\tIntegrate seamlessly with upstream and downstream workflows, including protein purification and structural analysis.\nThe procurement of a high-performance SPR system directly supports FMI’s broader goals of:\n•\tAccelerating drug discovery through rapid identification and characterisation of therapeutic candidates.\n•\tEnhancing biopharmaceutical research by enabling detailed analysis of binding mechanisms critical to biologics development.\n•\tFacilitating translational research by bridging fundamental molecular interaction studies with clinical and therapeutic applications.\nThis procurement will provide direct benefit to research scientists by:\n•\tReducing manual intervention and experimental variability through automation and streamlined workflows.\n•\tEnhancing data quality with high-resolution detection and advanced signal processing for accurate kinetic profiling.\n•\tPlease note: - The execution of this tender & contract will be solely dependent on grant funding being received, which is estimated to be confirmed in November 2025. \n•\tNo award will be made, or orders issued until the grant funding has been confirmed. If grant funding is not secured, the market will be notified, and this procurement exercise will be stood down.",
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure"
},
"parties": [
{
"id": "GB-NIC-101788",
"name": "Queen's University Belfast",
"roles": [
"buyer"
],
"address": {
"region": "UKN06",
"country": "GB",
"locality": "Belfast",
"postalCode": "BT7 1NN",
"countryName": "United Kingdom",
"streetAddress": "University Rd"
},
"details": {
"classifications": [
{
"id": "publicAuthoritySubCentralGovernment",
"scheme": "UK_CA_TYPE",
"description": "Public authority - sub-central government"
},
{
"id": "GB-NIR",
"scheme": "UK_CA_DEVOLVED_REGULATIONS",
"description": "Northern Irish devolved regulations apply"
}
]
},
"identifier": {
"id": "101788",
"scheme": "GB-NIC"
},
"contactPoint": {
"name": "Shauna Ryan",
"email": "procurement@qub.ac.uk"
}
},
{
"id": "GB-PPON-PRYY-4533-ZMZR",
"name": "Global Life Sciences Solutions Operations UK Limited",
"roles": [
"supplier"
],
"address": {
"region": "UKJ13",
"country": "GB",
"locality": "Little Chalfont,",
"postalCode": "HP7 9NA",
"countryName": "United Kingdom",
"streetAddress": "Amersham Place"
},
"details": {
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "PRYY-4533-ZMZR",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "tendersukie@cytiva.com"
}
}
],
"language": "en",
"contracts": [
{
"id": "1",
"title": "250262 - Contract for Supply, Delivery, Installation & Commissioning of a Surface Plasmon Resonance (SPR) System.",
"value": {
"currency": "GBP",
"amountGross": 700000
},
"period": {
"endDate": "2029-01-08T23:59:59+00:00",
"startDate": "2026-01-09T00:00:00+00:00",
"maxExtentDate": "2036-01-08T23:59:59+00:00"
},
"status": "active",
"awardID": "1",
"renewal": {
"description": "option to extend maintenance, software \nupdates/development, the supply of consumables and ancillary items, beyond this \nperiod for a further period of up to 10 years or the end of useful life of the \nequipment."
},
"documents": [
{
"id": "003495-2026",
"url": "https://www.find-tender.service.gov.uk/Notice/003495-2026",
"format": "text/html",
"noticeType": "UK7",
"description": "Contract details notice on Find a Tender",
"documentType": "contractNotice",
"datePublished": "2026-01-15T13:35:44Z"
}
],
"dateSigned": "2026-01-09T00:00:00+00:00",
"hasRenewal": true,
"aboveThreshold": true
}
],
"initiationType": "tender"
}{
"id": "085607-2025",
"tag": [
"award",
"contract"
],
"bids": {
"statistics": [
{
"id": "1",
"value": 1,
"measure": "bids",
"relatedLot": "1"
},
{
"id": "2",
"value": 1,
"measure": "finalStageBids",
"relatedLot": "1"
},
{
"id": "3",
"value": 0,
"measure": "smeFinalStageBids",
"relatedLot": "1"
},
{
"id": "4",
"value": 0,
"measure": "vcseFinalStageBids",
"relatedLot": "1"
}
]
},
"date": "2025-12-22T19:27:33Z",
"ocid": "ocds-h6vhtk-05cdd5",
"buyer": {
"id": "GB-NIC-101788",
"name": "Queen's University Belfast"
},
"awards": [
{
"id": "1",
"date": "2025-12-22T00:00:00+00:00",
"items": [
{
"id": "1",
"relatedLot": "1",
"additionalClassifications": [
{
"id": "38430000",
"scheme": "CPV",
"description": "Detection and analysis apparatus"
},
{
"id": "38432000",
"scheme": "CPV",
"description": "Analysis apparatus"
}
]
}
],
"value": {
"currency": "GBP",
"amountGross": 700000
},
"status": "pending",
"renewal": {
"description": "option to extend maintenance, software \nupdates/development, the supply of consumables and ancillary items, beyond this \nperiod for a further period of up to 10 years or the end of useful life of the \nequipment."
},
"documents": [
{
"id": "085607-2025",
"url": "https://www.find-tender.service.gov.uk/Notice/085607-2025",
"format": "text/html",
"noticeType": "UK6",
"description": "Contract award notice on Find a Tender",
"documentType": "awardNotice",
"datePublished": "2025-12-22T19:27:33Z"
}
],
"suppliers": [
{
"id": "GB-PPON-PRYY-4533-ZMZR",
"name": "Global Life Sciences Solutions Operations UK Limited"
}
],
"hasRenewal": true,
"milestones": [
{
"id": "1",
"type": "futureSignatureDate",
"status": "scheduled",
"dueDate": "2026-01-07T23:59:59+00:00"
}
],
"relatedLots": [
"1"
],
"aboveThreshold": true,
"contractPeriod": {
"endDate": "2029-01-08T23:59:59+00:00",
"startDate": "2026-01-09T00:00:00+00:00",
"maxExtentDate": "2036-01-08T23:59:59+00:00"
},
"standstillPeriod": {
"endDate": "2026-01-06T23:59:59+00:00"
},
"mainProcurementCategory": "goods",
"assessmentSummariesDateSent": "2025-12-22T00:00:00+00:00"
}
],
"tender": {
"id": "250262",
"lots": [
{
"id": "1",
"status": "complete"
}
],
"title": "250262 - Contract for Supply, Delivery, Installation & Commissioning of a Surface Plasmon Resonance (SPR) System.",
"status": "complete",
"legalBasis": {
"id": "2023/54",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents",
"scheme": "UKPGA"
},
"description": "The Future Medicines Institute (FMI) requires a Surface Plasmon Resonance (SPR) system with advanced capabilities for real-time, label-free analysis of biomolecular interactions.\n(Maximum budget available for Equipment inclusive of 3 years extended warranty & annual preventative maintenance is is £330,000).\nThe primary objective of procuring an SPR device is to enhance FMI’s capacity to characterise binding kinetics, affinity, and specificity of biomolecular interactions, thereby strengthening its protein science and drug discovery workflows.\nThe proposed system must:\n•\tProvide precise kinetic and affinity measurements for a wide range of biomolecular interactions, including protein–protein, protein–antibody, and protein–small molecule binding.\n•\tDeliver high sensitivity and reproducibility to ensure reliable and quantitative data across experiments.\n•\tSupport automation and high-throughput analysis, enabling efficient screening of large sample sets.\n•\tInclude robust data analysis software for comprehensive kinetic modelling and data interpretation.\n•\tOffer versatile assay configurations, supporting various experimental formats and immobilisation chemistries.\n•\tIntegrate seamlessly with upstream and downstream workflows, including protein purification and structural analysis.\nThe procurement of a high-performance SPR system directly supports FMI’s broader goals of:\n•\tAccelerating drug discovery through rapid identification and characterisation of therapeutic candidates.\n•\tEnhancing biopharmaceutical research by enabling detailed analysis of binding mechanisms critical to biologics development.\n•\tFacilitating translational research by bridging fundamental molecular interaction studies with clinical and therapeutic applications.\nThis procurement will provide direct benefit to research scientists by:\n•\tReducing manual intervention and experimental variability through automation and streamlined workflows.\n•\tEnhancing data quality with high-resolution detection and advanced signal processing for accurate kinetic profiling.\n•\tPlease note: - The execution of this tender & contract will be solely dependent on grant funding being received, which is estimated to be confirmed in November 2025. \n•\tNo award will be made, or orders issued until the grant funding has been confirmed. If grant funding is not secured, the market will be notified, and this procurement exercise will be stood down.",
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure"
},
"parties": [
{
"id": "GB-NIC-101788",
"name": "Queen's University Belfast",
"roles": [
"buyer"
],
"address": {
"region": "UKN06",
"country": "GB",
"locality": "Belfast",
"postalCode": "BT7 1NN",
"countryName": "United Kingdom",
"streetAddress": "University Rd"
},
"details": {
"classifications": [
{
"id": "publicAuthoritySubCentralGovernment",
"scheme": "UK_CA_TYPE",
"description": "Public authority - sub-central government"
},
{
"id": "GB-NIR",
"scheme": "UK_CA_DEVOLVED_REGULATIONS",
"description": "Northern Irish devolved regulations apply"
}
]
},
"identifier": {
"id": "101788",
"scheme": "GB-NIC"
},
"contactPoint": {
"name": "Shauna Ryan",
"email": "procurement@qub.ac.uk"
}
},
{
"id": "GB-PPON-PRYY-4533-ZMZR",
"name": "Global Life Sciences Solutions Operations UK Limited",
"roles": [
"supplier"
],
"address": {
"region": "UKJ13",
"country": "GB",
"locality": "Little Chalfont",
"postalCode": "HP7 9NA",
"countryName": "United Kingdom",
"streetAddress": "Amersham Place"
},
"details": {
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "PRYY-4533-ZMZR",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "tendersukie@cytiva.com"
}
}
],
"language": "en",
"initiationType": "tender"
}{
"id": "072246-2025",
"tag": [
"tenderUpdate"
],
"date": "2025-11-10T08:46:19Z",
"ocid": "ocds-h6vhtk-05cdd5",
"buyer": {
"id": "GB-NIC-101788",
"name": "Queen's University Belfast"
},
"tender": {
"id": "250262",
"lots": [
{
"id": "1",
"value": {
"amount": 700000,
"currency": "AED",
"amountGross": 700000
},
"status": "active",
"renewal": {
"description": "Option to extend maintenance, software updates/development, the supply of consumables and ancillary items, beyond this period for a further period of up to 10 years or the end of useful life of the equipment."
},
"hasRenewal": true,
"awardCriteria": {
"criteria": [
{
"name": "Simple description",
"type": "price",
"description": "Technical - 50%: Made up of-\nDesirable Technical Requirements - 30%\nQualitative requirements - 15%\nSustainable Procurement - 5%\nPrice - 50%"
}
],
"weightingDescription": "Technical - 50%: Made up of-\nDesirable Technical Requirements - 30%\nQualitative requirements - 15%\nSustainable Procurement - 5%\nPrice - 50%"
},
"contractPeriod": {
"endDate": "2035-12-21T23:59:59+00:00",
"startDate": "2025-12-22T00:00:00+00:00",
"maxExtentDate": "2045-12-21T23:59:59+00:00"
}
}
],
"items": [
{
"id": "1",
"relatedLot": "1",
"deliveryAddresses": [
{
"region": "UKN06",
"country": "GB",
"countryName": "United Kingdom"
}
],
"additionalClassifications": [
{
"id": "38430000",
"scheme": "CPV",
"description": "Detection and analysis apparatus"
},
{
"id": "38432000",
"scheme": "CPV",
"description": "Analysis apparatus"
}
]
}
],
"title": "250262 - Contract for Supply, Delivery, Installation & Commissioning of a Surface Plasmon Resonance (SPR) System.",
"value": {
"amount": 700000,
"currency": "GBP",
"amountGross": 700000
},
"status": "active",
"documents": [
{
"id": "L-1",
"url": "https://in-tendhost.co.uk/queensuniversitybelfast/aspx/Home",
"description": "Intend tender portal",
"documentType": "biddingDocuments"
},
{
"id": "conflictOfInterest",
"description": "Not published",
"documentType": "conflictOfInterest"
},
{
"id": "072246-2025",
"url": "https://www.find-tender.service.gov.uk/Notice/072246-2025",
"format": "text/html",
"noticeType": "UK4",
"description": "Tender notice on Find a Tender",
"documentType": "tenderNotice",
"datePublished": "2025-11-10T08:46:19Z"
}
],
"amendments": [
{
"id": "072246-2025",
"description": "Amendment made to Tender response pack to enable suppliers to upload 2 x A4 pages instead of 1 x A4 pages for qualitative response questions.\n10.11.25 - Update in regards to clarification:- Bidders are strongly advised to review both the tender specification and the Clarification Document in full before submitting their response. Both documents are available on the procurement portal."
}
],
"legalBasis": {
"id": "2023/54",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents",
"scheme": "UKPGA"
},
"awardPeriod": {
"endDate": "2025-12-22T23:59:59+00:00"
},
"description": "The Future Medicines Institute (FMI) requires a Surface Plasmon Resonance (SPR) system with advanced capabilities for real-time, label-free analysis of biomolecular interactions.\n(Maximum budget available for Equipment inclusive of 3 years extended warranty & annual preventative maintenance is is £330,000).\nThe primary objective of procuring an SPR device is to enhance FMI’s capacity to characterise binding kinetics, affinity, and specificity of biomolecular interactions, thereby strengthening its protein science and drug discovery workflows.\nThe proposed system must:\n•\tProvide precise kinetic and affinity measurements for a wide range of biomolecular interactions, including protein–protein, protein–antibody, and protein–small molecule binding.\n•\tDeliver high sensitivity and reproducibility to ensure reliable and quantitative data across experiments.\n•\tSupport automation and high-throughput analysis, enabling efficient screening of large sample sets.\n•\tInclude robust data analysis software for comprehensive kinetic modelling and data interpretation.\n•\tOffer versatile assay configurations, supporting various experimental formats and immobilisation chemistries.\n•\tIntegrate seamlessly with upstream and downstream workflows, including protein purification and structural analysis.\nThe procurement of a high-performance SPR system directly supports FMI’s broader goals of:\n•\tAccelerating drug discovery through rapid identification and characterisation of therapeutic candidates.\n•\tEnhancing biopharmaceutical research by enabling detailed analysis of binding mechanisms critical to biologics development.\n•\tFacilitating translational research by bridging fundamental molecular interaction studies with clinical and therapeutic applications.\nThis procurement will provide direct benefit to research scientists by:\n•\tReducing manual intervention and experimental variability through automation and streamlined workflows.\n•\tEnhancing data quality with high-resolution detection and advanced signal processing for accurate kinetic profiling.\n•\tPlease note: - The execution of this tender & contract will be solely dependent on grant funding being received, which is estimated to be confirmed in November 2025. \n•\tNo award will be made, or orders issued until the grant funding has been confirmed. If grant funding is not secured, the market will be notified, and this procurement exercise will be stood down.",
"riskDetails": "QUB recognises that certain risks associated with the procurement and operation of an SPR System are not fully quantifiable at the time of tender. These ‘known unknowns’ include, but are not limited to, supplier failure and switching costs, technology evolution, integration challenges, data security, regulatory changes, user training & turnover, warranty & service coverage, supply chain disruptions, and software lifecycle changes, increased value or scope due to demand requirements. Suppliers are expected to identify any foreseeable risks, propose mitigation strategies, and demonstrate flexibility in addressing emerging issues throughout the contract lifecycle.\nWhilst it is not possible at this stage to fully anticipate the nature or extent of future developments or integration requirements, nor to determine their potential impact on contract performance, QUB recognises that such changes may arise over the course of the contract. Accordingly, it is acknowledged that these circumstances may necessitate a modification of the contract to appropriately address and accommodate any emerging risks or requirements.",
"tenderPeriod": {
"endDate": "2025-11-14T16:00:00+00:00"
},
"contractTerms": {
"financialTerms": "after delivery - 30 days upon receipt of a valid and undisputed invoice"
},
"enquiryPeriod": {
"endDate": "2025-11-07T16:00:00+00:00"
},
"aboveThreshold": true,
"submissionTerms": {
"languages": [
"en"
],
"electronicSubmissionPolicy": "allowed"
},
"procurementMethod": "open",
"mainProcurementCategory": "goods",
"submissionMethodDetails": "https://in-tendhost.co.uk/queensuniversitybelfast/aspx/Home",
"procurementMethodDetails": "Open procedure"
},
"parties": [
{
"id": "GB-NIC-101788",
"name": "Queen's University Belfast",
"roles": [
"buyer"
],
"address": {
"region": "UKN06",
"country": "GB",
"locality": "Belfast",
"postalCode": "BT7 1NN",
"countryName": "United Kingdom",
"streetAddress": "University Rd"
},
"details": {
"classifications": [
{
"id": "publicAuthoritySubCentralGovernment",
"scheme": "UK_CA_TYPE",
"description": "Public authority - sub-central government"
},
{
"id": "GB-NIR",
"scheme": "UK_CA_DEVOLVED_REGULATIONS",
"description": "Northern Irish devolved regulations apply"
}
]
},
"identifier": {
"id": "101788",
"scheme": "GB-NIC"
},
"contactPoint": {
"name": "Shauna Ryan",
"email": "procurement@qub.ac.uk"
}
}
],
"language": "en",
"initiationType": "tender"
}{
"id": "068436-2025",
"tag": [
"tenderUpdate"
],
"date": "2025-10-27T10:26:17Z",
"ocid": "ocds-h6vhtk-05cdd5",
"buyer": {
"id": "GB-NIC-101788",
"name": "Queen's University Belfast"
},
"tender": {
"id": "250262",
"lots": [
{
"id": "1",
"value": {
"amount": 700000,
"currency": "AED",
"amountGross": 700000
},
"status": "active",
"renewal": {
"description": "Option to extend maintenance, software updates/development, the supply of consumables and ancillary items, beyond this period for a further period of up to 10 years or the end of useful life of the equipment."
},
"hasRenewal": true,
"awardCriteria": {
"criteria": [
{
"name": "Simple description",
"type": "price",
"description": "Technical - 50%: Made up of-\nDesirable Technical Requirements - 30%\nQualitative requirements - 15%\nSustainable Procurement - 5%\nPrice - 50%"
}
],
"weightingDescription": "Technical - 50%: Made up of-\nDesirable Technical Requirements - 30%\nQualitative requirements - 15%\nSustainable Procurement - 5%\nPrice - 50%"
},
"contractPeriod": {
"endDate": "2035-12-21T23:59:59+00:00",
"startDate": "2025-12-22T00:00:00+00:00",
"maxExtentDate": "2045-12-21T23:59:59+00:00"
}
}
],
"items": [
{
"id": "1",
"relatedLot": "1",
"deliveryAddresses": [
{
"region": "UKN06",
"country": "GB",
"countryName": "United Kingdom"
}
],
"additionalClassifications": [
{
"id": "38430000",
"scheme": "CPV",
"description": "Detection and analysis apparatus"
},
{
"id": "38432000",
"scheme": "CPV",
"description": "Analysis apparatus"
}
]
}
],
"title": "250262 - Contract for Supply, Delivery, Installation & Commissioning of a Surface Plasmon Resonance (SPR) System.",
"value": {
"amount": 700000,
"currency": "GBP",
"amountGross": 700000
},
"status": "active",
"documents": [
{
"id": "L-1",
"url": "https://in-tendhost.co.uk/queensuniversitybelfast/aspx/Home",
"description": "Intend tender portal",
"documentType": "biddingDocuments"
},
{
"id": "conflictOfInterest",
"description": "Not published",
"documentType": "conflictOfInterest"
},
{
"id": "068436-2025",
"url": "https://www.find-tender.service.gov.uk/Notice/068436-2025",
"format": "text/html",
"noticeType": "UK4",
"description": "Tender notice on Find a Tender",
"documentType": "tenderNotice",
"datePublished": "2025-10-27T10:26:17Z"
}
],
"amendments": [
{
"id": "068436-2025",
"description": "Amendment made to Tender response pack to enable suppliers to upload 2 x A4 pages instead of 1 x A4 pages for qualitative response questions."
}
],
"legalBasis": {
"id": "2023/54",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents",
"scheme": "UKPGA"
},
"awardPeriod": {
"endDate": "2025-12-22T23:59:59+00:00"
},
"description": "The Future Medicines Institute (FMI) requires a Surface Plasmon Resonance (SPR) system with advanced capabilities for real-time, label-free analysis of biomolecular interactions.\n(Maximum budget available for Equipment inclusive of 3 years extended warranty & annual preventative maintenance is is £330,000).\nThe primary objective of procuring an SPR device is to enhance FMI’s capacity to characterise binding kinetics, affinity, and specificity of biomolecular interactions, thereby strengthening its protein science and drug discovery workflows.\nThe proposed system must:\n•\tProvide precise kinetic and affinity measurements for a wide range of biomolecular interactions, including protein–protein, protein–antibody, and protein–small molecule binding.\n•\tDeliver high sensitivity and reproducibility to ensure reliable and quantitative data across experiments.\n•\tSupport automation and high-throughput analysis, enabling efficient screening of large sample sets.\n•\tInclude robust data analysis software for comprehensive kinetic modelling and data interpretation.\n•\tOffer versatile assay configurations, supporting various experimental formats and immobilisation chemistries.\n•\tIntegrate seamlessly with upstream and downstream workflows, including protein purification and structural analysis.\nThe procurement of a high-performance SPR system directly supports FMI’s broader goals of:\n•\tAccelerating drug discovery through rapid identification and characterisation of therapeutic candidates.\n•\tEnhancing biopharmaceutical research by enabling detailed analysis of binding mechanisms critical to biologics development.\n•\tFacilitating translational research by bridging fundamental molecular interaction studies with clinical and therapeutic applications.\nThis procurement will provide direct benefit to research scientists by:\n•\tReducing manual intervention and experimental variability through automation and streamlined workflows.\n•\tEnhancing data quality with high-resolution detection and advanced signal processing for accurate kinetic profiling.\n•\tPlease note: - The execution of this tender & contract will be solely dependent on grant funding being received, which is estimated to be confirmed in November 2025. \n•\tNo award will be made, or orders issued until the grant funding has been confirmed. If grant funding is not secured, the market will be notified, and this procurement exercise will be stood down.",
"riskDetails": "QUB recognises that certain risks associated with the procurement and operation of an SPR System are not fully quantifiable at the time of tender. These ‘known unknowns’ include, but are not limited to, supplier failure and switching costs, technology evolution, integration challenges, data security, regulatory changes, user training & turnover, warranty & service coverage, supply chain disruptions, and software lifecycle changes, increased value or scope due to demand requirements. Suppliers are expected to identify any foreseeable risks, propose mitigation strategies, and demonstrate flexibility in addressing emerging issues throughout the contract lifecycle.\nWhilst it is not possible at this stage to fully anticipate the nature or extent of future developments or integration requirements, nor to determine their potential impact on contract performance, QUB recognises that such changes may arise over the course of the contract. Accordingly, it is acknowledged that these circumstances may necessitate a modification of the contract to appropriately address and accommodate any emerging risks or requirements.",
"tenderPeriod": {
"endDate": "2025-11-14T16:00:00+00:00"
},
"contractTerms": {
"financialTerms": "after delivery - 30 days upon receipt of a valid and undisputed invoice"
},
"enquiryPeriod": {
"endDate": "2025-11-07T16:00:00+00:00"
},
"aboveThreshold": true,
"submissionTerms": {
"languages": [
"en"
],
"electronicSubmissionPolicy": "allowed"
},
"procurementMethod": "open",
"mainProcurementCategory": "goods",
"submissionMethodDetails": "https://in-tendhost.co.uk/queensuniversitybelfast/aspx/Home",
"procurementMethodDetails": "Open procedure"
},
"parties": [
{
"id": "GB-NIC-101788",
"name": "Queen's University Belfast",
"roles": [
"buyer"
],
"address": {
"region": "UKN06",
"country": "GB",
"locality": "Belfast",
"postalCode": "BT7 1NN",
"countryName": "United Kingdom",
"streetAddress": "University Rd"
},
"details": {
"classifications": [
{
"id": "publicAuthoritySubCentralGovernment",
"scheme": "UK_CA_TYPE",
"description": "Public authority - sub-central government"
},
{
"id": "GB-NIR",
"scheme": "UK_CA_DEVOLVED_REGULATIONS",
"description": "Northern Irish devolved regulations apply"
}
]
},
"identifier": {
"id": "101788",
"scheme": "GB-NIC"
},
"contactPoint": {
"name": "Shauna Ryan",
"email": "procurement@qub.ac.uk"
}
}
],
"language": "en",
"initiationType": "tender"
}{
"id": "066106-2025",
"tag": [
"tender"
],
"date": "2025-10-17T08:28:37+01:00",
"ocid": "ocds-h6vhtk-05cdd5",
"buyer": {
"id": "GB-NIC-101788",
"name": "Queen's University Belfast"
},
"tender": {
"id": "250262",
"lots": [
{
"id": "1",
"value": {
"amount": 700000,
"currency": "AED",
"amountGross": 700000
},
"status": "active",
"renewal": {
"description": "Option to extend maintenance, software updates/development, the supply of consumables and ancillary items, beyond this period for a further period of up to 10 years or the end of useful life of the equipment."
},
"hasRenewal": true,
"awardCriteria": {
"criteria": [
{
"name": "Simple description",
"type": "price",
"description": "Technical - 50%: Made up of-\nDesirable Technical Requirements - 30%\nQualitative requirements - 15%\nSustainable Procurement - 5%\nPrice - 50%"
}
],
"weightingDescription": "Technical - 50%: Made up of-\nDesirable Technical Requirements - 30%\nQualitative requirements - 15%\nSustainable Procurement - 5%\nPrice - 50%"
},
"contractPeriod": {
"endDate": "2035-12-21T23:59:59+00:00",
"startDate": "2025-12-22T00:00:00+00:00",
"maxExtentDate": "2045-12-21T23:59:59+00:00"
}
}
],
"items": [
{
"id": "1",
"relatedLot": "1",
"deliveryAddresses": [
{
"region": "UKN06",
"country": "GB",
"countryName": "United Kingdom"
}
],
"additionalClassifications": [
{
"id": "38430000",
"scheme": "CPV",
"description": "Detection and analysis apparatus"
},
{
"id": "38432000",
"scheme": "CPV",
"description": "Analysis apparatus"
}
]
}
],
"title": "250262 - Contract for Supply, Delivery, Installation & Commissioning of a Surface Plasmon Resonance (SPR) System.",
"value": {
"amount": 700000,
"currency": "GBP",
"amountGross": 700000
},
"status": "active",
"documents": [
{
"id": "L-1",
"url": "https://in-tendhost.co.uk/queensuniversitybelfast/aspx/Home",
"description": "Intend tender portal",
"documentType": "biddingDocuments"
},
{
"id": "conflictOfInterest",
"description": "Not published",
"documentType": "conflictOfInterest"
},
{
"id": "066106-2025",
"url": "https://www.find-tender.service.gov.uk/Notice/066106-2025",
"format": "text/html",
"noticeType": "UK4",
"description": "Tender notice on Find a Tender",
"documentType": "tenderNotice",
"datePublished": "2025-10-17T08:28:37+01:00"
}
],
"legalBasis": {
"id": "2023/54",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents",
"scheme": "UKPGA"
},
"awardPeriod": {
"endDate": "2025-12-22T23:59:59+00:00"
},
"description": "The Future Medicines Institute (FMI) requires a Surface Plasmon Resonance (SPR) system with advanced capabilities for real-time, label-free analysis of biomolecular interactions.\n(Maximum budget available for Equipment inclusive of 3 years extended warranty & annual preventative maintenance is is £330,000).\nThe primary objective of procuring an SPR device is to enhance FMI’s capacity to characterise binding kinetics, affinity, and specificity of biomolecular interactions, thereby strengthening its protein science and drug discovery workflows.\nThe proposed system must:\n•\tProvide precise kinetic and affinity measurements for a wide range of biomolecular interactions, including protein–protein, protein–antibody, and protein–small molecule binding.\n•\tDeliver high sensitivity and reproducibility to ensure reliable and quantitative data across experiments.\n•\tSupport automation and high-throughput analysis, enabling efficient screening of large sample sets.\n•\tInclude robust data analysis software for comprehensive kinetic modelling and data interpretation.\n•\tOffer versatile assay configurations, supporting various experimental formats and immobilisation chemistries.\n•\tIntegrate seamlessly with upstream and downstream workflows, including protein purification and structural analysis.\nThe procurement of a high-performance SPR system directly supports FMI’s broader goals of:\n•\tAccelerating drug discovery through rapid identification and characterisation of therapeutic candidates.\n•\tEnhancing biopharmaceutical research by enabling detailed analysis of binding mechanisms critical to biologics development.\n•\tFacilitating translational research by bridging fundamental molecular interaction studies with clinical and therapeutic applications.\nThis procurement will provide direct benefit to research scientists by:\n•\tReducing manual intervention and experimental variability through automation and streamlined workflows.\n•\tEnhancing data quality with high-resolution detection and advanced signal processing for accurate kinetic profiling.\n•\tPlease note: - The execution of this tender & contract will be solely dependent on grant funding being received, which is estimated to be confirmed in November 2025. \n•\tNo award will be made, or orders issued until the grant funding has been confirmed. If grant funding is not secured, the market will be notified, and this procurement exercise will be stood down.",
"riskDetails": "QUB recognises that certain risks associated with the procurement and operation of an SPR System are not fully quantifiable at the time of tender. These ‘known unknowns’ include, but are not limited to, supplier failure and switching costs, technology evolution, integration challenges, data security, regulatory changes, user training & turnover, warranty & service coverage, supply chain disruptions, and software lifecycle changes, increased value or scope due to demand requirements. Suppliers are expected to identify any foreseeable risks, propose mitigation strategies, and demonstrate flexibility in addressing emerging issues throughout the contract lifecycle.\nWhilst it is not possible at this stage to fully anticipate the nature or extent of future developments or integration requirements, nor to determine their potential impact on contract performance, QUB recognises that such changes may arise over the course of the contract. Accordingly, it is acknowledged that these circumstances may necessitate a modification of the contract to appropriately address and accommodate any emerging risks or requirements.",
"tenderPeriod": {
"endDate": "2025-11-14T16:00:00+00:00"
},
"contractTerms": {
"financialTerms": "after delivery - 30 days upon receipt of a valid and undisputed invoice"
},
"enquiryPeriod": {
"endDate": "2025-11-07T16:00:00+00:00"
},
"aboveThreshold": true,
"submissionTerms": {
"languages": [
"en"
],
"electronicSubmissionPolicy": "allowed"
},
"procurementMethod": "open",
"mainProcurementCategory": "goods",
"submissionMethodDetails": "https://in-tendhost.co.uk/queensuniversitybelfast/aspx/Home",
"procurementMethodDetails": "Open procedure"
},
"parties": [
{
"id": "GB-NIC-101788",
"name": "Queen's University Belfast",
"roles": [
"buyer"
],
"address": {
"region": "UKN06",
"country": "GB",
"locality": "Belfast",
"postalCode": "BT7 1NN",
"countryName": "United Kingdom",
"streetAddress": "University Rd"
},
"details": {
"classifications": [
{
"id": "publicAuthoritySubCentralGovernment",
"scheme": "UK_CA_TYPE",
"description": "Public authority - sub-central government"
},
{
"id": "GB-NIR",
"scheme": "UK_CA_DEVOLVED_REGULATIONS",
"description": "Northern Irish devolved regulations apply"
}
]
},
"identifier": {
"id": "101788",
"scheme": "GB-NIC"
},
"contactPoint": {
"name": "Shauna Ryan",
"email": "procurement@qub.ac.uk"
}
}
],
"language": "en",
"initiationType": "tender"
}{
"id": "065844-2025",
"tag": [
"planning"
],
"date": "2025-10-16T11:24:42+01:00",
"ocid": "ocds-h6vhtk-05cdd5",
"buyer": {
"id": "GB-NIC-101788",
"name": "Queen's University Belfast"
},
"tender": {
"id": "250262",
"lots": [
{
"id": "1",
"status": "planning",
"hasRenewal": true,
"suitability": {
"sme": true
},
"contractPeriod": {
"endDate": "2035-12-21T23:59:59+00:00",
"startDate": "2025-12-22T00:00:00+00:00",
"maxExtentDate": "2045-12-21T23:59:59+00:00"
}
}
],
"items": [
{
"id": "1",
"relatedLot": "1",
"deliveryAddresses": [
{
"region": "UKN06",
"country": "GB",
"countryName": "United Kingdom"
}
],
"additionalClassifications": [
{
"id": "38430000",
"scheme": "CPV",
"description": "Detection and analysis apparatus"
},
{
"id": "38432000",
"scheme": "CPV",
"description": "Analysis apparatus"
}
]
}
],
"title": "250262 - Contract for Supply, Delivery, Installation & Commissioning of a Surface Plasmon Resonance (SPR) System.",
"status": "planning",
"legalBasis": {
"id": "2023/54",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents",
"scheme": "UKPGA"
},
"description": "The Future Medicines Institute (FMI) requires a Surface Plasmon Resonance (SPR) system with advanced capabilities for real-time, label-free analysis of biomolecular interactions.\n(Maximum budget available for Equipment inclusive of 3 years extended warranty & annual preventative maintenance is is £330,000).\nThe primary objective of procuring an SPR device is to enhance FMI’s capacity to characterise binding kinetics, affinity, and specificity of biomolecular interactions, thereby strengthening its protein science and drug discovery workflows.\nThe proposed system must:\n•\tProvide precise kinetic and affinity measurements for a wide range of biomolecular interactions, including protein–protein, protein–antibody, and protein–small molecule binding.\n•\tDeliver high sensitivity and reproducibility to ensure reliable and quantitative data across experiments.\n•\tSupport automation and high-throughput analysis, enabling efficient screening of large sample sets.\n•\tInclude robust data analysis software for comprehensive kinetic modelling and data interpretation.\n•\tOffer versatile assay configurations, supporting various experimental formats and immobilisation chemistries.\n•\tIntegrate seamlessly with upstream and downstream workflows, including protein purification and structural analysis.\nThe procurement of a high-performance SPR system directly supports FMI’s broader goals of:\n•\tAccelerating drug discovery through rapid identification and characterisation of therapeutic candidates.\n•\tEnhancing biopharmaceutical research by enabling detailed analysis of binding mechanisms critical to biologics development.\n•\tFacilitating translational research by bridging fundamental molecular interaction studies with clinical and therapeutic applications.\nThis procurement will provide direct benefit to research scientists by:\n•\tReducing manual intervention and experimental variability through automation and streamlined workflows.\n•\tEnhancing data quality with high-resolution detection and advanced signal processing for accurate kinetic profiling.\n•\tPlease note: - The execution of this tender & contract will be solely dependent on grant funding being received, which is estimated to be confirmed in November 2025. \n•\tNo award will be made, or orders issued until the grant funding has been confirmed. If grant funding is not secured, the market will be notified, and this procurement exercise will be stood down.",
"communication": {
"futureNoticeDate": "2025-10-17T23:59:59+01:00"
},
"mainProcurementCategory": "goods"
},
"parties": [
{
"id": "GB-NIC-101788",
"name": "Queen's University Belfast",
"roles": [
"buyer"
],
"address": {
"region": "UKN06",
"country": "GB",
"locality": "Belfast",
"postalCode": "BT7 1NN",
"countryName": "United Kingdom",
"streetAddress": "University Rd"
},
"details": {
"classifications": [
{
"id": "publicAuthoritySubCentralGovernment",
"scheme": "UK_CA_TYPE",
"description": "Public authority - sub-central government"
},
{
"id": "GB-NIR",
"scheme": "UK_CA_DEVOLVED_REGULATIONS",
"description": "Northern Irish devolved regulations apply"
}
]
},
"identifier": {
"id": "101788",
"scheme": "GB-NIC"
},
"contactPoint": {
"email": "procurement@qub.ac.uk"
}
}
],
"language": "en",
"planning": {
"documents": [
{
"id": "065844-2025",
"url": "https://www.find-tender.service.gov.uk/Notice/065844-2025",
"format": "text/html",
"noticeType": "UK2",
"description": "Preliminary market engagement notice on Find a Tender",
"documentType": "marketEngagementNotice",
"datePublished": "2025-10-16T11:24:42+01:00"
}
],
"milestones": [
{
"id": "engagement",
"type": "engagement",
"status": "met",
"dateMet": "2025-10-07T00:00:00+01:00",
"description": "Summary of Informal Preliminary Market Engagement \nQueen’s has conducted Preliminary Market Engagement with a number of suppliers in order to: \n•\tdevelop the understanding of our requirements and the proposed approach to the procurement; \n•\tgain a better understanding of what the market can offer and if the market was capable of responding to a tender in relation to this requirement; \n•\tidentify potential suppliers for the requirement; \n•\tunderstand potential lead times; \n•\tgain an understanding of the commercial profile for the requirement; \n•\tcommunicate sustainability targets and minimum requirements to confirm the market has the capability to deliver on these. \n•\tidentify opportunities to reduce the environmental impact of the requirement. \nThe information gathered from PME will be used to shape any forthcoming procurement strategy to ensure that requirements can be subject to reasonable competitive tension. \nParticipation in preliminary market engagement is not a prerequisite for any future tender exercise."
}
]
},
"initiationType": "tender"
}